The coordinator of both the INCTR's Strategy Groups, Ethical Committee and Director of INCTR's Clinical Trials Office, as well as managing its ongoing clinical studies
Riccardo AUDISIO (UK)
The chief editor of the “Surgical Oncology” journal. He works as a surgical oncologist, consultant and reader at University of Liverpool. His research focuses on Onco-Geriatrics and breast cancer. He is the chief scientific advisor to ICEDOC and SEMCO.
Otis BRAWLEY (USA)
Professor of hematology, oncology, and medicine at the Emory University School of Medicine. He is the Deputy Director for Cancer Control and Population Science at Winship Cancer Institute.
Monir KINAY (Turkey)
The chairman of Radiation Oncology Department, Izmir, Turkey. He has wide scientific and educational activities particularly with ESTRO. He is one of the main founders of ICEDOC and a chief scientific advisor to SEMCO.
Tony MOK (China)
Professor of Clinical Oncology, Chinese University of Hong Kong. He has been very active in both clinical and laboratory research in the areas of lung cancer, liver cancer and traditional Chinese medicine.
Ian MAGRATH (USA, Belgium)
President of INCTR (International Network for Cancer Treatment and Research). He is a leading international expert in the treatment of non-Hodgkin's lymphomas and in the treatment of pediatric cancers.
Sandra SWAIN (USA)
The Director of the Washington Cancer Institute, and Professor of Medicine. Her scientific endeavors have focused on the therapy of breast cancer.
Andrea VERONESI (Italy)
Head of Medical Oncology and Department of Senology, Centro di Riferimento Oncologico, Aviano, Italy. He is one of the main founders of ICEDOC (International Campaign for Establishment and Development Oncology Centers, USA). Within UICC he performed educational activities in several Countries. He is a chief scientific advisor to ICEDOC and SEMCO